Cross Border Outbound Ma India

On a Tuesday in late July 2025, Tata Motors did something no Indian company had done at this scale before. It agreed to buy Iveco Group, the Turin-based truck-and-bus maker spun out of the old Fiat empire, for roughly €3.8 billion in an all-cash offer pitched at €14.1 a share. Strip out Iveco's defence arm, fold in the financing, and the enterprise commitment swelled toward $4.45 billion. It was, by Tata's own reckoning, the largest acquisition in the group's history. Bigger than Jaguar Land Rover in 2008. Bigger than Corus. And to fund it, Tata Motors went out and syndicated a €3.875 billion bridge loan, an instrument that tells you everything about how seriously India Inc. now takes the business of buying abroad.

The Iveco deal did not happen in isolation. It sat at the top of a year in which the entire architecture of Indian dealmaking tilted outward. Cross-border M&A involving India surged 155% to $33.2 billion in 2025, up from $13 billion the year before, even as the raw number of cross-border deals actually fell by a fifth. Read those two numbers together and you have the headline of the era: fewer transactions, far larger cheques, and a decisive shift from incremental bolt-ons toward the kind of trophy assets that move a company's centre of gravity. Within that, the outbound leg, Indian acquirers buying foreign targets, nearly tripled from $5.1 billion in 2024 to $13.7 billion in 2025.

This is the third instalment in our running series on M&A opportunities in India, and it is the one where the story flips. The earlier pieces tracked capital flowing in. This one is about capital, ambition and balance-sheet confidence flowing the other way, and about a smaller but consequential set of inbound control deals that are quietly redrawing who owns what. India is going shopping. The questions worth asking are what it is buying, why now, and whether the cheques being written today will look prescient or reckless from the vantage point of 2030.

The 155% Number and What Sits Underneath It

Start with the macro frame, because it disciplines everything that follows. India's total M&A value rose to $123.8 billion in 2025, an 18% jump from $106.3 billion in 2024, even as overall volumes slipped about 3%. The pattern repeats at every cut of the data: deal counts flat to down, deal values sharply up, average ticket sizes ballooning. Buyout value alone has nearly quadrupled over the decade, from roughly ₹364 billion in 2016 to ₹1,380 billion in 2025, which tells you control, not minority growth capital, is now where the conviction lives.

Cross-border activity is the most dramatic expression of that conviction. The $33.2 billion figure is not a rounding artefact. It represents a genuine regime change in how Indian boards think about geography. For most of the past two decades, the outbound story was episodic. A Tata-Corus here, a Bharti-Zain there, a Hindalco-Novelis, each a landmark precisely because landmarks were rare. The acquisitions came in bursts, usually debt-financed, frequently followed by years of indigestion. What changed in 2025 is that outbound stopped being episodic and started looking structural.

The timing inside the year is itself instructive. Outbound deal value clustered around two peaks. July 2025 recorded close to $6 billion of outbound value in a single month, driven by the Tata-Iveco announcement, and December produced another surge. These were not steady drips. They were a handful of very large transactions landing in concentrated windows, which is exactly what you would expect when the driver is strategic repositioning by a small number of large, cash-generative groups rather than broad-based opportunism across the mid-market.

Why the volume-value divergence matters

When volumes fall and values rise, it usually means one of two things. Either credit has tightened and only the biggest, best-capitalised players can transact, or the strategic logic has concentrated around a smaller set of must-have assets. In India's case it is mostly the second. The cost of capital did not collapse in 2025, but the largest Indian corporates, the Tatas, the Sun Pharmas, the Coforges, were sitting on the strongest balance sheets in their histories, with access to dollar funding that simply did not exist a cycle ago. The constraint was never money. It was nerve, and target availability. In 2025 both arrived at once.

The other thing the divergence signals is selectivity. India's acquirers are not spraying capital. They are running concentrated bets on assets they believe materially change their competitive position. That selectivity is the through-line connecting deals that otherwise look unrelated, a truck maker, a women's-health pharma portfolio, a Latin American engineering shop. In each case the buyer was reaching for a specific capability or market position that would have taken a decade or more to build organically.

Capability-Buying: The New Logic of the Outbound Deal

The old outbound playbook was about scale and cost. Buy a distressed Western asset, bring Indian operating discipline, arbitrage the labour and capital differential, and wait. The new playbook is about capability. India Inc. has discovered that the fastest route to skills it lacks, embedded engineering, regulated-market access, proprietary IP, deep client relationships in markets it cannot easily penetrate, is to write a cheque for the firm that already has them.

Tata-Iveco is partly a capability play dressed as a scale play. Yes, the combined entity will move over 540,000 commercial vehicles a year with combined revenues near €22 billion, split across Europe at 50%, India at 35% and the Americas at 15%. That is scale. But the deeper rationale is product and technology complementarity, Iveco's European heavy-truck engineering, emissions know-how and dealer footprint slotting into Tata's volume manufacturing and growth-market reach. Tata could not have built a credible European heavy-commercial-vehicle franchise from scratch. It bought one.

Coforge-Encora and the engineering-services land grab

The purest capability deal of the cycle came in December 2025, when Coforge agreed to acquire Encora at an enterprise value of $2.35 billion through a share-swap structure, funded via a preferential allotment representing roughly $1.89 billion of equity, with Encora's shareholders, including Advent and Warburg Pincus, ending up with about 20% of the enlarged Coforge. Encora brings around $600 million of projected FY26 revenue at a roughly 19% adjusted EBITDA margin, and the combined firm vaults toward a $2.5 billion services powerhouse anchored on a $2 billion core of AI-led engineering, data and cloud.

Strip away the financial engineering and what Coforge bought was talent and a delivery footprint in geographies and verticals it wanted faster than it could grow into them. In a services market being reshaped by AI, the scarce asset is not headcount, it is the right kind of engineering depth, and Coforge decided the cheaper path was acquisition. The deal cleared its statutory and regulatory hurdles across multiple jurisdictions by April 2026, which in itself is a marker of how much more confidently Indian acquirers now run multi-country approvals.

Wipro-HARMAN: buying embedded talent at the source

Wipro made the same calculation in a different register. In December 2025 it closed its acquisition of HARMAN's Digital Transformation Solutions business, a Samsung-owned unit, folding more than 5,600 employees across the Americas, Europe and Asia into Wipro's Engineering Global Business Line. The attraction was specific, deep product-engineering and embedded-software capability, plus expertise in embodied AI, device engineering and customer-experience platforms. This is talent acquisition at industrial scale, the kind of embedded-systems competence that an Indian IT major cannot conjure out of a campus hiring drive. You buy the team that already ships the product.

Across these three deals the pattern is unmistakable. The asset being purchased is not a factory or a customer list in the abstract. It is institutionalised capability, the accumulated, hard-to-replicate know-how of an organisation that has been doing a hard thing for a long time. India Inc. has stopped trying to copy that know-how and started buying it outright. For boards weighing build-versus-buy, the maths increasingly favours buy, because in a world moving this fast the most expensive resource is time.

Pharma and the CDMO Bet: Buying Into the Regulated World

If engineering services is the loudest theme, pharmaceuticals is the deepest. Indian pharma's outbound activity in 2025 ran along two tracks at once, the headline-grabbing mega-deal and a quieter, arguably more strategic, stream of contract-development-and-manufacturing acquisitions.

The mega-deal is Sun Pharma's pursuit of Organon, announced in 2026 and pitched at a figure that would make it among the largest outbound transactions ever attempted by an Indian company, with reports putting the value as high as $11.75 billion and even references to a $12 billion structure. State Bank of India was reported to be lining up to lead around $1 billion of the financing. Organon would hand Sun a built-out portfolio across women's health, biosimilars and dermatology, plus the regulatory and commercial infrastructure to sell it in developed markets. That last part is the prize. Indian pharma has world-class manufacturing economics and patchy access to high-value Western channels. Buying Organon is buying the channel.

The CDMO acquisitions are the smarter tell

The mega-deals make headlines, but the CDMO acquisitions reveal where the sector's strategic thinking is sharpest. India's pharma exports are nearing $30 billion, and the CRDMO and contract-manufacturing segment is increasingly seen as the growth engine for the next phase. Indian firms responded by buying regulated-market manufacturing and chemistry expertise abroad.

In February 2025, Granules India acquired the Swiss CDMO Senn Chemicals AG for around CHF 20 million, roughly ₹192.5 crore, picking up specialised peptide-synthesis capability across both liquid-phase and solid-phase routes, plus an established European customer base and regulatory standing. Gujarat Themis Biosyn went after MicroBiopharm Japan in a deal valued around ₹1,300 crore, combining India's cost-efficient fermentation base with Japanese regulatory strength and access to global markets. These are not vanity purchases. They are precise acquisitions of regulatory credibility and niche chemistry that an Indian player cannot easily originate, the kind of capability that takes years to qualify with Western and Japanese regulators.

The logic mirrors the IT story. Buy the regulatory pedigree, buy the specialised process knowledge, buy the relationships with demanding customers. India's manufacturing-cost advantage is real but commoditised. What is scarce, and therefore worth acquiring, is the trust and qualification that lets you sell into the most demanding markets at premium margins. The CDMO deals are India Inc. paying up for entry into the regulated world rather than waiting a decade to be let in.

Deglobalisation Hedging: Buying Your Way Around the Tariff Wall

There is a defensive logic running beneath much of this outbound activity, and it has a name: deglobalisation. The world is fragmenting into trading blocs, supply chains are being re-shored and friend-shored, and the United States has wielded tariffs of up to 50% on certain Indian exports. For Indian companies whose growth thesis rested on exporting from India to the West, that is an existential question. The answer, increasingly, is to own assets inside the markets you sell to.

EY's reading of the 2025 data is blunt on this point: Indian corporates are adopting a deliberately strategic posture, acquiring overseas assets that help them diversify and fortify share in key markets, explicitly to balance the volatility in trade flows unleashed by evolving US tariff policy. If you cannot reliably ship into a market, you manufacture or deliver inside it, and the fastest way to be inside it is to buy a company that already is. The tariff wall stops goods at the border. It does not stop ownership.

The textiles-and-engineering squeeze

The pressure is sharpest at the bottom of the export pyramid. US tariffs have heightened the strain on MSMEs, textiles and engineering goods, the segments least able to absorb a 50% levy or relocate production. India's policy response has been to diversify trade relationships, with the EFTA agreement taking effect and active negotiations with the UK and the Gulf Cooperation Council. But policy moves slowly, and corporates with shareholders to answer to have moved faster, hedging by acquiring footholds in alternative geographies and inside the tariff perimeter itself.

This reframes a deal like Tata-Iveco. It is not only a capability and scale play. It is a geographic hedge. With manufacturing and revenue distributed across Europe, India and the Americas, the combined entity is far less exposed to any single country's trade policy than a pure India-based exporter would be. The same logic threads through the pharma CDMO buys, owning manufacturing in Switzerland and Japan, not just qualifying products from India, insulates the business from the next tariff shock. Ownership becomes insurance. In a deglobalising world, the M&A budget doubles as a geopolitical hedging budget.

GIFT City: The Structuring Platform Comes of Age

Every wave of cross-border dealmaking needs plumbing, the legal and financial vehicles through which capital actually moves. For Indian outbound flows, that plumbing is increasingly running through GIFT City, the International Financial Services Centre in Gujarat that has spent years being talked about and is now, finally, being used.

The numbers have inflected hard. Outbound capital commitments routed through GIFT City jumped from $170.99 million in September 2023 to $1.43 billion by June 2025, an eightfold surge in under two years, with wealth managers projecting annual outbound deployments could reach $3 to $4 billion. Total commitments across GIFT City's alternative-investment-fund ecosystem surged 117% year-on-year to $26.3 billion by September 2025, from $12.1 billion a year earlier. That is the trajectory of a platform crossing from pilot to infrastructure.

What the 2025 regulations unlocked

The acceleration is partly regulatory design. The International Financial Services Centres Authority's Fund Management Regulations of 2025 introduced a plug-and-play IFSC fund platform letting domestic and international managers launch India-focused, cross-border and global strategies through the IFSC, cutting the time, cost and complexity of standing up a fund. The minimum AIF investment was lowered from $150,000 to $75,000 per investor, and the overseas-portfolio-investment route for pooled vehicles was channelled specifically through GIFT City structures.

The significance for outbound M&A is structural. GIFT City gives Indian capital an onshore-offshore gateway, a way to pool and deploy money into global assets with a tax and regulatory regime designed to be competitive with Singapore and Dubai, without the friction of fully offshoring. For a group assembling the financing and holding structure for a foreign acquisition, or for the family offices and institutions co-investing alongside corporate buyers, the IFSC is becoming the default first stop. The wave of outbound deals and the build-out of GIFT City are not coincidental. The platform is part of what makes the wave executable at this velocity. The structuring layer has caught up with the strategic ambition.

The Inbound Counter-Current: Control Deals Redrawing Ownership

Outbound dominates the narrative, but the inbound side of the ledger carries its own significance, and a different kind of signal. Where outbound is about India Inc. reaching out, inbound control deals are about global capital deciding that owning a controlling stake in an Indian asset is worth a premium it would not have paid a few years ago. The shift from minority growth investing toward control is the defining inbound trend of the cycle.

The landmark sits in the financial sector. Early in Q4 2025, Emirates NBD announced the acquisition of a controlling stake in RBL Bank through a primary infusion of roughly $3 billion, around ₹26,850 crore, the largest acquisition in Indian banking and the biggest foreign investment in Indian financial services. A foreign bank taking control of an Indian lender at that scale is a genuine first, and a marker of how far the regulatory and political tolerance for foreign control has moved when the capital is strategic and the target needs the balance-sheet support.

Private equity moves decisively toward control

Private equity has been pulling in the same direction. But the texture matters more than the totals. Buyouts, minority growth investments with control features, and platform acquisitions dominated the activity, and buyout value nearly quadrupled over the decade to ₹1,380 billion. Average deal size jumped 34% as values rose 23% against an 8% decline in volumes. The capital is concentrating, and it is buying control.

The largest single PE transaction of the year underlines the theme: in September, International Holding Company, the Abu Dhabi conglomerate, invested $1 billion for a 43.5% stake in Sammaan Capital, a significant bet in the NBFC space and another vote of confidence in Indian financial services from Gulf capital specifically. Read alongside Emirates NBD-RBL, a pattern emerges of Middle Eastern strategic capital taking large, control-oriented positions in Indian financials, a corridor that barely existed a cycle ago and is now among the most active.

What the inbound control deals share with the outbound wave is the death of incrementalism. On both sides of the border, the action has moved to large, control-defining transactions executed by well-capitalised strategic and financial buyers. The minority-stake, hope-for-the-best growth cheque has given way to the buy-it-and-run-it conviction bet. That is a more mature market, and a more consequential one, because control deals reshape governance, strategy and ownership in ways that minority rounds never do.

The Risk Ledger: What Could Go Wrong

A wave this large invites its own cautionary reading, and any honest deals desk has to keep the risk ledger open alongside the deal log. The history of Indian outbound M&A is not an unbroken record of triumph. Corus nearly sank Tata Steel's balance sheet for the better part of a decade. The 2008-vintage outbound spree produced as many write-downs as wins. The fact that the current wave is bigger and better-financed does not make it immune to the same failure modes, and in some respects raises the stakes.

Leverage is the first concern. Tata Motors syndicating a €3.875 billion bridge to fund Iveco, Sun Pharma reportedly arranging billions in financing for Organon, these are debt-heavy structures executed at a moment when global rates, while off their peak, are nowhere near the cheap money of the 2010s. A bridge loan is a promise to refinance, and refinancing windows can close. If integration stumbles or the acquired asset underperforms in its first two years, the financing that looked prudent at signing can become the thing that defines the deal. Debt-funded outbound acquisitions have a long history of looking brilliant on announcement day and punishing on the third anniversary.

Integration and the capability paradox

The second concern is integration, and it is sharpened by the very logic driving the wave. When you buy capability, you are buying people and culture, the least portable assets in any transaction. Coforge folding in Encora's engineers, Wipro absorbing 5,600 HARMAN employees across three continents, Tata integrating Turin's engineering culture, each of these is a human-capital integration challenge dressed as a financial transaction. The capability you paid a premium for can walk out the door if the integration is mishandled. The asset is the team, and teams are mobile.

There is also a concentration risk at the macro level. Because the wave is driven by a small number of very large deals from a small number of very large groups, the headline numbers are vulnerable to a handful of outcomes. If the Tata-Iveco or Sun-Organon integrations falter visibly, the chilling effect on board-level appetite for outbound risk could be disproportionate, precisely because so much of the narrative rests on so few transactions. A wave concentrated in a few names is a wave that can be reversed by a few disappointments.

And then there is the regulatory and geopolitical layer. Multi-jurisdiction approvals are getting smoother, but they are not getting simpler, and the same deglobalisation that motivates the hedging also raises the odds that a cross-border deal gets caught in a foreign-investment-review net or a national-security screen. Owning assets inside the tariff wall is a hedge, but it also means exposure to the political risk of whatever jurisdiction you have just bought into. The insurance has its own premium.

Reading the Wave: What the Smart Money Is Actually Betting On

Step back from the individual transactions and the wave resolves into a coherent thesis about where India Inc. believes value will sit over the next decade. It is a bet on three things at once, and they reinforce each other.

The first bet is that capability is scarcer than capital. For the largest Indian groups, money is no longer the binding constraint, dollar funding is available, balance sheets are strong, and GIFT City has lowered the friction of structuring cross-border deployment. What is scarce is institutionalised know-how in engineering, regulated manufacturing, and developed-market commercial access. So the capital is being spent to buy the capability, fast, while the targets are available and the financing windows are open. That is a rational allocation in a world where time-to-capability is the real competitive moat.

The second bet is that geographic diversification is now a survival requirement, not a growth luxury. The tariff shocks of 2025 made concrete what had been an abstract risk, that a business model resting on exporting from India to the West is exposed to political decisions entirely outside its control. Owning assets inside multiple blocs is the hedge, and M&A is the fastest route to ownership. The Indian companies buying abroad in 2025 are, in part, buying optionality against a world that keeps fragmenting.

The third bet, visible on the inbound side, is that control beats minority. Whether it is Emirates NBD taking the wheel at RBL, IHC's $1 billion control-flavoured stake in Samman, or the quadrupling of buyout value over the decade, the capital that is moving with conviction wants to own and operate, not to ride along. That preference for control is itself a statement of confidence, you only pay the control premium when you believe in your ability to run the asset better than the seller did.

Put those three bets together and the 155% surge stops looking like a spike and starts looking like the early innings of a structural reorientation. India spent two decades as a market that capital came to. It is now, simultaneously, a market that buys, a market that gets bought into at the control level, and a jurisdiction that increasingly structures its own cross-border flows through its own financial centre. That is what a maturing capital market looks like from the inside.

The cheques being written in this wave, €3.8 billion for a truck maker, $2.35 billion for an engineering firm, the better part of $12 billion for a pharma portfolio, will not all age well. Some will be the next Corus, a strategic logic undone by leverage and integration. But the direction is not in doubt. The Tata Motors board that approved Iveco was not making an opportunistic punt. It was acting on a conviction now shared across India Inc.: that the way to compete in a fragmenting world is to own pieces of it, and that the moment to buy is while you still can. The shopping has only just begun, and the most interesting deals in this series are the ones that have not been announced yet.